Mauricio Alberto Realpe-Quintero

Prof. Mauricio Alberto Realpe-Quintero

University of Guadalajara, Guadalajara, Jalisco, Mexico
orcid
Full professor

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2009 in Journal of Virology
Verified
Journal Article
Open access
KBKarin Bok
Karin Bok
EAEugenio J. Abente
Eugenio J. Abente
Mauricio Alberto Realpe-QuinteroMauricio Alberto Realpe-Quintero
Mauricio Alberto Realpe-Quintero
TMTanaji Mitra
Tanaji Mitra
SSStanislav V. Sosnovtsev
Stanislav V. Sosnovtsev
KGKim Y. Green
Kim Y. Green
Noroviruses are a major cause of epidemic gastroenteritis in children and adults, and GII.4 has been the predominant genotype since its first documented occurrence in 1987. This study examined the evolutionary dynamics of GII.4 noroviruses over more than three decades to investigate possible mechanisms by which these viruses have emerged to become predominant. Stool samples ( n = 5,424) from children hospitalized at the Children's Hospital in Washington, DC, between 1974 and 1991 were screened for the presence of noroviruses by a custom multiplex real-time reverse transcription-PCR. The complete genome sequences of five GII.4 noroviruses (three of which predate 1987 by more than a decade) in this archival collection were determined and compared to the sequences of contemporary strains. Evolutionary analysis determined that the GII.4 VP1 capsid gene evolved at a rate of 4.3 × 10 −3 nucleotide substitutions/site/year. Only six sites in the VP1 capsid protein were found to evolve under positive selection, most of them located in the shell domain. No unique mutations were observed in or around the two histoblood group antigen (HBGA) binding sites in the P region, indicating that this site has been conserved since the 1970s. The VP1 proteins from the 1974 to 1977 noroviruses contained a unique sequence of four consecutive amino acids in the P2 region, which formed an exposed protrusion on the modeled capsid structure. This protrusion and other observed sequence variations did not affect the HBGA binding profiles of recombinant virus-like particles derived from representative 1974 and 1977 noroviruses compared with more recent noroviruses. Our analysis of archival GII.4 norovirus strains suggests that this genotype has been circulating for more than three decades and provides new ancestral strain sequences for the analysis of GII.4 evolution.

1 May 2004 in Virology
Verified
Journal Article
Closed access
PIPavel Iša
Pavel Iša
Mauricio Alberto Realpe-QuinteroMauricio Alberto Realpe-Quintero
Mauricio Alberto Realpe-Quintero
PRPedro Romero
Pedro Romero
SLSusana Lopez
Susana Lopez
CACarlos F Arias
Carlos F Arias

21 February 2016 in World Journal of Gastroenterology
Verified
Journal Article
Open access
NFNora A Fierro
Nora A Fierro
Mauricio Alberto Realpe-QuinteroMauricio Alberto Realpe-Quintero
Mauricio Alberto Realpe-Quintero
TMTzintli Meraz-Medina
Tzintli Meraz-Medina
SRSonia Roman
Sonia Roman
APArturo Panduro
Arturo Panduro
Hepatitis E virus (HEV) infection is a common cause of acute clinical hepatitis worldwide. HEV is an RNA-containing virus and the only member of the genus Hepevirus in the family Hepeviridae. Human HEV is classified into four genotypes widely distributed across the world. The virus is mainly transmitted via the fecal-oral route, and water-borne epidemics have become characteristic of hepatitis E in developing countries, including those in Latin America. The zoonotic potential of HEV is broadly recognized. Thus, there is an urgent need to re-evaluate virus transmission scenarios and to enforce epidemiological surveillance systems. Additionally, it is known that HEV infections, initially defined as self-limiting, can also take chronic courses in immunocompromised patients. Moreover, we recently reported a high seroprevalence of HEV in samples from cirrhotic patients with no other etiological agents present, suggesting the potential role of HEV in the development of chronic liver illness. In this review, HEV genomic variability, transmission, chronic infectious course, zoonotic potential and treatment are discussed. Focus is placed on the impact of HEV infection in Latin America, to support the development of specific control strategies and the handling of this important and typically imperceptible viral infection.

1 October 1998 in Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology
Verified
Journal Article
Closed access
SOSergio Orduz
Sergio Orduz
Mauricio Alberto Realpe-QuinteroMauricio Alberto Realpe-Quintero
Mauricio Alberto Realpe-Quintero
RARafael E. Arango-Isaza
Rafael E. Arango-Isaza
LMLuis Angel Murillo
Luis Angel Murillo
ADArmelle Delécluse
Armelle Delécluse

26 July 2022 in Poultry Science
Verified
Journal Article
Open access
LMLizbeth Mendoza-González
Lizbeth Mendoza-González
AMAna Marandino
Ana Marandino
YPYanina Panzera
Yanina Panzera
GTGonzalo Tomás
Gonzalo Tomás
JWJoaquín Williman
Joaquín Williman
RPRuben Pérez
Ruben Pérez
The avian infectious bronchitis virus (IBV) is a highly mutable coronavirus that causes an acute and highly contagious disease responsible for economic losses to the poultry industry worldwide. Preventing and controlling bronchitis disease is difficulted by the numerous IBV circulating types with limited antigenic cross-protection that hamper the prevention and control by heterologous vaccines. The coding region of the variable spike S1 receptor-attachment domain is used to classify IBV in 7 genotypes (GI–GVII) comprising 35 viral lineages (1–35). Knowledge of the circulating IBV types causing outbreaks in a specific geographic region is beneficial to select better the appropriate vaccine(s) and contribute to disease control. In the study, 17 avian infectious bronchitis virus strains were obtained from chickens showing signs of illness in Mexico from 2007 to 2021. We detected 4 lineages within genotype I, three already known (GI-3, GI-9, GI-13) and one newly described (GI-30). In addition, we identified 2 divergent monophyletic groups that are tentatively described as lineages of new genotypes (GVIII-1 and GIX-1). Our findings revealed that Mexico's high genetic IBV diversity results from the co-circulation of divergent lineages belonging to different genotypes. Mexican IBV lineages differ significantly from Massachusetts and Connecticut vaccine strains, indicating that the currently used vaccines may need to be updated.

1 December 2011 in Memórias do Instituto Oswaldo Cruz
Verified
Journal Article
Open access
PDF file
Nora A. FierroNora A. Fierro
Nora A. Fierro
SRSonia Roman
Sonia Roman
Mauricio Alberto Realpe-QuinteroMauricio Alberto Realpe-Quintero
Mauricio Alberto Realpe-Quintero
ZHZamira Helena Hernández-Nazará
Zamira Helena Hernández-Nazará
ECEloy A Zepeda Carrillo
Eloy A Zepeda Carrillo
APArturo Panduro
Arturo Panduro
A high prevalence of occult hepatitis B (OHB) genotype H infections has been observed in the native Mexican Nahua population. In addition, a low incidence of hepatitis B virus (HBV)-associated hepatocellular carcinoma has been described in Mexico. The immune response to infection among OHB-infected patients has been poorly evaluated in vivo. Therefore, we assessed the expression profiles of 23 cytokines in OHB genotype H-infected Nahua patients. A total of 41 sera samples from natives of the Nahua community were retrospectively analysed. Based on their HBV antibody profiles, patients were stratified into two groups: OHB patients (n = 21) and patients that had recovered from HBV infection (n = 20). Herein, we report distinctive cytokines profiles in OHB-infected individuals. Compared to healthy controls (n = 20) and patients who resolved HBV infection, OHB-infected patients displayed an increase in interleukin (IL)-2 secretion in addition to a characteristic inflammation profile (decrease in IL-8 and tumour necrosis factor-alpha levels and increased levels of tumour growth factor-beta). IL-15 and interferon-gamma levels were reduced in OHB-infected individuals when compared to those patients who resolved HBV infection. In contrast, OHB patients showed an increase in monocyte chemoattractant protein (MCP)-1 and MCP-2 compared to healthy controls and patients who resolved HBV infection. These findings suggest that cytokine expression can influence the severity of OHB disease and could lead to new investigation into the treatment of liver and other infectious diseases.